Periodontopathogens antibodies and major adverse events following an acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI)

Autor: Boillot, A, Range, H, Danchin, N, Kotti, S, Cosler, G, Czernichow, S, Meilhac, O, Puymirat, E, Zeller, M, Tchetche, D, Bouchard, P, Simon, T

Publikováno v: Journal of Epidemiology and Community Health (1979-), 2016 Dec 01. 70(12), 1236-1241.

Externí odkaz: http://www.jstor.org/stable/44133791

1700P Impact of sarcomatoid (S) and rhabdoid (R) components (comp.) on the efficacy of nivolumab (N) +/- ipilimumab (I) in the first-line (L1) treatment of metastatic clear cell renal cell carcinoma (mRCC) in the randomized phase II BIONIKK trial

Autor: Vano, Y-A., Hernandez, I., Bennamoun, M., Verkarre, V., Chevreau, C.M., Gross Goupil, M., Tournigand, C., Borchiellini, D., Laguerre, B., Maillet, D., Barthelemy, P., Gravis, G., Coquan, E., Pannier, D., Houede, N., Kotti, S., Fridman, W-H., Sautes-Fridman, C., Sun, C-M., Oudard, S.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S1019-S1019

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

1808P Pain response and health-related quality of life (HRQL) analysis in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel every 2 weeks (16 mg/m2) versus every 3 weeks (25 mg/m2) in the CABASTY phase III trial

Autor: Oudard, S., Ratta, R., Voog, E., Barthelemy, P., Thiery-Vuillemin, A., Bennamoun, M., Hasbini, A., Aldabbagh, K., Saldana, C., Von Amsberg, G., Houede, N., Besson, D., Feyerabend, S., Boegemann, M., Falcoz, A., Vernerey, D., Belhouari, H., Kotti, S., Tran, Y., Helissey, C.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S978-S979

Cholesteryl Ester Transfer Protein Polymorphisms, Statin Use, and Their Impact on Cholesterol Levels and Cardiovascular Events

Autor: André, Romain, Elbaz, Meyer, Khalife, Khalife, Lim, Pascal, Ennezat, Pierre-Vladimir, Coste, Pierre, Le Breton, Hervé, Bataille, Vincent, Ferrières, Jean, Leusink, M, Onland-Moret, N, Asselbergs, F, Ding, B, Kotti, S, van Zuydam, N, Papp, A, Danchin, Nicolas, Donnelly, L, Morris, A, Chasman, D, Doevendans, P, Klungel, O, Ridker, P, van Gilst, W, Simon, Tabassome, Nyberg, F, Palmer, C, Sadee, W, van Der Harst, P, de Bakker, P, de Boer, A, Verstuyft, C, Maitland-van Der Zee, A

Publikováno v: Clinical Pharmacology & Therapeutics, 95(3), 314-320. Nature Publishing Group
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 2013, 95 (2), pp.314-320. ⟨10.1038/clpt.2013.194⟩
Clinical Pharmacology and Therapeutics, American Society for Clinical Pharmacology and Therapeutics, 2013, 95 (2), pp.314-320. ⟨10.1038/clpt.2013.194⟩

The association of nonfunctional variants of the cholesteryl ester transfer protein (CETP) with efficacy of statins has been a subject of debate. We evaluated whether three functional CETP variants influence statin efficacy. The effect of CETP genoty

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b506750d275a06613213d70721bc6ea2
https://research.rug.nl/en/publications/5a3ef928-2c6d-4690-8431-8458826c1ee4